3
Announcements
Trials
Browse
Landscape
Status
Recruiting
1
Sponsor Class
OTHER
1
Study Type
Observational
1
Sponsor
Cancer Type
Plasma cell
1
Other hematologic neoplasm
1
Conditions
Multiple Myeloma
2
Hematologic Neoplasms
2
Leukemia, Plasma Cell
1
Infections
1
Immunoglobulin Light-chain Amyloidosis
1
Interventions
Trimethoprim, Sulfamethoxazole Drug Combination
5
Ciprofloxacin
4
gamma-Globulins
3
Caspofungin
3
Amoxicillin-Potassium Clavulanate Combination
3
liposomal amphotericin B
2
Voriconazole
2
Polymerase Chain Reaction
2
Pentetic Acid
2
Moxifloxacin
2
Levofloxacin
2
Itraconazole
2
Immunoglobulins, Intravenous
2
Fluconazole
2
talquetamab
1
idecabtagene vicleucel
1
gilteritinib
1
fludarabine phosphate
1
ethanolamine oleate
1
drotrecogin alfa activated
1
amphotericin B, deoxycholate drug combination
1
X-Rays
1
Whole-Body Irradiation
1
Watchful Waiting
1
Vancomycin
1
Valacyclovir
1
Trimethoprim
1
Therapeutics
1
Tazobactam
1
Tacrolimus
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Infections
×
talquetamab
×
Other hematologic neoplasm
×
Clear all
NCT06855121
2025-03-03
NIMMS
St. Olavs Hospital
Recruiting
400 enrolled